Search

Your search keyword '"Treat-Jacobson D"' showing total 123 results

Search Constraints

Start Over You searched for: Author "Treat-Jacobson D" Remove constraint Author: "Treat-Jacobson D"
123 results on '"Treat-Jacobson D"'

Search Results

2. Cardiovascular health: The importance of measuring patient-reported health status

8. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six-month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study.

12. Review: exercise programmes increase walking times in patients with intermittent claudication.

13. ACCF/AHA/ACR/SCAI/SIR/SVM/SVN/SVS 2010 Performance Measures for Adults With Peripheral Artery Disease A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures, the American College of Radiology, the Society for Cardiac Angiography and Interventions, the Society for Interventional Radiology, the Society for Vascular Medicine, the Society for Vascular Nursing, and the Society for Vascular Surgery (Writing Committee to Develop Clinical Performance Measures for Peripheral Artery Disease) Developed in Collaboration With the American Association of Cardiovascular and Pulmonary Rehabilitation; the American Diabetes Association; the Society for Atherosclerosis Imaging and Prevention; the Society for Cardiovascular Magnetic Resonance; the Society of Cardiovascular Computed Tomography; and the PAD Coalition Endorsed by the American Academy of Podiatric Practice Management.

14. Home-Based Exercise and Patient-Reported Outcome Measures in Peripheral Artery Disease: The LITE Randomized Clinical Trial.

15. Impact of chemotherapy-induced peripheral neuropathy on physical function in pediatric cancer survivors: a systematic review.

16. Symptom Descriptors in Individuals Living With Undiagnosed Lower Extremity Peripheral Artery Disease.

17. 2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

18. Uptake and outcomes of supervised exercise therapy for peripheral artery disease: The importance of vascular medicine specialists at a large midwestern health care system during the first 5 years of CMS reimbursement.

20. Hospitalizations during home-based walking exercise interventions in peripheral artery disease: Results from two randomized clinical trials.

21. Study Design, Rationale, and Methodology for Promote Weight Loss in Patients With Peripheral Artery Disease Who Also Have Obesity: The PROVE Trial.

22. Clinical Effectiveness of a Supervised Exercise Therapy Program for Treatment of Peripheral Artery Disease: A Translational Study.

23. Relation of non-exercise walking activity with exercise performance in patients with peripheral artery disease: NEW activity for PAD.

24. Characterizing patient-reported claudication treatment goals to support patient-centered treatment selection and measurement strategies.

25. Barriers to participation in supervised exercise therapy reported by people with peripheral artery disease.

26. Supervised Exercise Therapy for Symptomatic Peripheral Artery Disease: A REVIEW OF CURRENT EXPERIENCE AND PRACTICE-BASED RECOMMENDATIONS.

27. Effects of Walking Exercise at a Pace With Versus Without Ischemic Leg Symptoms on Functional Performance Measures in People With Lower Extremity Peripheral Artery Disease: The LITE Randomized Clinical Trial.

28. Decision Aids for Determining Facility Versus Non-Facility-Based Exercise in Those with Symptomatic Peripheral Artery Disease.

30. Total body recumbent stepping vs treadmill walking in supervised exercise therapy: A pilot study.

31. Sustained physical activity in peripheral artery disease: Associations with disease severity, functional performance, health-related quality of life, and subsequent serious adverse events in the LITE randomized clinical trial.

32. Geographic and Socioeconomic Disparities in Major Lower Extremity Amputation Rates in Metropolitan Areas.

33. Individual Differences in Response to Supervised Exercise Therapy for Peripheral Artery Disease.

34. Effect of Low-Intensity vs High-Intensity Home-Based Walking Exercise on Walk Distance in Patients With Peripheral Artery Disease: The LITE Randomized Clinical Trial.

35. Influence of Changes in Sedentary Time on Outcomes of Supervised Exercise Therapy in Individuals with Comorbid Peripheral Artery Disease and Type 2 Diabetes.

36. Adherence and exercise mode in supervised exercise therapy for peripheral artery disease.

38. Membership spotlight.

42. Implementation of Supervised Exercise Therapy for Patients With Symptomatic Peripheral Artery Disease: A Science Advisory From the American Heart Association.

44. A mixed methods study of perceived barriers to physical activity, geriatric syndromes, and physical activity levels among older adults with peripheral artery disease and diabetes.

45. Experience Implementing Supervised Exercise Therapy for Peripheral Artery Disease.

46. Optimal Exercise Programs for Patients With Peripheral Artery Disease: A Scientific Statement From the American Heart Association.

47. Variability in Individual Response to Aerobic Exercise Interventions Among Older Adults.

49. Power of Peer Support to Change Health Behavior to Reduce Risks for Heart Disease and Stroke for African American Men in a Faith-Based Community.

Catalog

Books, media, physical & digital resources